Absence of Rejection in a Facial Allograft Recipient with a Positive Flow Crossmatch 24 Months after Induction with Rabbit Anti-Thymocyte Globulin and Anti-CD20 Monoclonal Antibody

<div>Graphic representation of induction immunosuppression regimen for presented face transplant recipient. The cumulative dose of rabbit antithymocyte globulin (ATG) reached 6 mg/kg (total of 575 mg). Patient also received tacrolimus and mycophenolate mofetil (MMF) en route to the operating room for the facial transplant procedure. The shaded area indicates the initiation of maintenance immunosuppression.</div>

Case Reports in Transplantation

fig1

Figure 1

Figure 1: Absence of Rejection in a Facial Allograft Recipient with a Positive Flow Crossmatch 24 Months after Induction with Rabbit Anti-Thymocyte Globulin and Anti-CD20 Monoclonal Antibody 

Figure 1 | Absence of Rejection in a Facial Allograft Recipient with a Positive Flow Crossmatch 24 Months after Induction with Rabbit Anti-Thymocyte Globulin and Anti-CD20 Monoclonal Antibody 